CAPTRUST Financial Advisors
VINC

CAPTRUST Financial Advisors’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-71
Closed -$2K – 4216
2022
Q2 		$2K Buy
71
+33
+87% +$1.47K ﹤0.01% 4534
2022
Q1 		$3K Buy
+38
New +$4.69K ﹤0.01% 4403
2021
Q4 		– Sell
-4
Closed -$1K – 4952
2021
Q3 		$1K Buy
+4
New +$1.17K ﹤0.01% 4514

Other funds holding VINC

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

CAPTRUST Financial Advisors's VINC Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2022, closing a stake of 71 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in VINC in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 42 funds tracked by Wall St. Rank hold VINC as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 71 Vincerx Pharma, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Vincerx Pharma, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's Vincerx Pharma, Inc. Common Stock position peaked at $3K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.